Earnings Outlook For Cyclacel Pharmaceuticals
Portfolio Pulse from Benzinga Insights
Cyclacel Pharmaceuticals (NASDAQ:CYCC) is anticipated to report its quarterly earnings on 2024-03-19, with an expected EPS of $-5.89. The company's past earnings performance shows a history of not meeting EPS estimates, leading to significant share price drops. Shares are currently trading at $2.43, reflecting a 73.11% decrease over the last year. Investors are looking for positive guidance for the next quarter.
March 18, 2024 | 3:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Cyclacel Pharmaceuticals is expected to report an EPS of $-5.89 for the upcoming quarter. Historical performance shows a trend of not meeting EPS estimates, which has previously resulted in significant share price declines.
Given Cyclacel Pharmaceuticals' history of not meeting EPS estimates and the subsequent negative impact on its share price, it is likely that any deviation from the expected EPS could result in a short-term negative impact on the stock. The anticipation of the earnings report and the company's guidance for the next quarter are crucial for investors, especially considering the stock's 73.11% decline over the last year.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100